Jurgen Leohold - Aug 2, 2021 Form 4 Insider Report for QuantumScape Corp (QS)

Role
Director
Signature
/s/ Kevin Hettrich, attorney-in-fact
Stock symbol
QS
Transactions as of
Aug 2, 2021
Transactions value $
-$1,922,476
Form type
4
Date filed
8/4/2021, 05:00 PM
Previous filing
Jun 14, 2021
Next filing
Dec 13, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QS Class A Common Stock Options Exercise $66.3K +50K +51.39% $1.33* 147K Aug 2, 2021 Direct
transaction QS Class A Common Stock Sale -$893K -39.8K -27.04% $22.41 107K Aug 2, 2021 Direct F1
transaction QS Class A Common Stock Sale -$237K -10.2K -9.46% $23.31 97.3K Aug 2, 2021 Direct F2
transaction QS Class A Common Stock Options Exercise $238K +100K +102.78% $2.38 197K Aug 3, 2021 Direct
transaction QS Class A Common Stock Sale -$742K -34.2K -17.32% $21.70 163K Aug 3, 2021 Direct F3
transaction QS Class A Common Stock Sale -$350K -15.6K -9.58% $22.44 147K Aug 3, 2021 Direct F4
transaction QS Class A Common Stock Sale -$4.61K -200 -0.14% $23.04 147K Aug 3, 2021 Direct F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QS Stock Option (right to buy) Options Exercise $0 -50K -24.73% $0.00 152K Aug 2, 2021 Class A Common Stock 50K $1.33 Direct F6
transaction QS Stock Option (right to buy) Options Exercise $0 -100K -24.86% $0.00 302K Aug 3, 2021 Class A Common Stock 100K $2.38 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.985, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.02 to $23.70, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.54 to $21.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.00 to $22.87, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.00 to $23.07, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
F6 20% of the shares subject to the option vested and became exercisable on January 1, 2019, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.
F7 20% of the shares subject to the option will vest and become exercisable on December 11, 2020, and the remaining shares will vest monthly thereafter, subject to the Reporting Person's continued service at each vesting date.